Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
66.52
+0.25 (0.38%)
At close: Feb 18, 2026, 4:00 PM EST
66.53
+0.01 (0.02%)
After-hours: Feb 18, 2026, 7:00 PM EST
PBH Revenue
Prestige Consumer Healthcare had revenue of $283.44M in the quarter ending December 31, 2025, a decrease of -2.37%. This brings the company's revenue in the last twelve months to $1.10B, down -1.31% year-over-year. In the fiscal year ending March 31, 2025, Prestige Consumer Healthcare had annual revenue of $1.14B with 1.10% growth.
Revenue (ttm)
$1.10B
Revenue Growth
-1.31%
P/S Ratio
2.85
Revenue / Employee
$1,839,343
Employees
600
Market Cap
3.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.14B | 12.41M | 1.10% |
| Mar 31, 2024 | 1.13B | -2.37M | -0.21% |
| Mar 31, 2023 | 1.13B | 40.91M | 3.76% |
| Mar 31, 2022 | 1.09B | 143.45M | 15.21% |
| Mar 31, 2021 | 943.37M | -19.65M | -2.04% |
| Mar 31, 2020 | 963.01M | -12.77M | -1.31% |
| Mar 31, 2019 | 975.78M | -65.40M | -6.28% |
| Mar 31, 2018 | 1.04B | 159.12M | 18.04% |
| Mar 31, 2017 | 882.06M | 75.81M | 9.40% |
| Mar 31, 2016 | 806.25M | 91.62M | 12.82% |
| Mar 31, 2015 | 714.62M | 117.24M | 19.63% |
| Mar 31, 2014 | 597.38M | -22.74M | -3.67% |
| Mar 31, 2013 | 620.12M | 179.03M | 40.59% |
| Mar 31, 2012 | 441.09M | 104.58M | 31.08% |
| Mar 31, 2011 | 336.51M | 43.91M | 15.01% |
| Mar 31, 2010 | 292.60M | -1.74M | -0.59% |
| Mar 31, 2009 | 294.35M | -20.76M | -6.59% |
| Mar 31, 2008 | 315.11M | -3.53M | -1.11% |
| Mar 31, 2007 | 318.63M | 21.97M | 7.40% |
| Mar 31, 2006 | 296.67M | 7.60M | 2.63% |
| Mar 31, 2005 | 289.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.03B |
| Perrigo Company | 4.28B |
| Amneal Pharmaceuticals | 2.93B |
| Hims & Hers Health | 2.21B |
| Lantheus Holdings | 1.53B |
| Alkermes | 1.52B |
| Phibro Animal Health | 1.46B |
| Supernus Pharmaceuticals | 681.54M |
PBH News
- 5 days ago - Heartland Opportunistic Value Equity Strategy Q4 2025 Portfolio Activity - Seeking Alpha
- 13 days ago - Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Premium Brands: Setting Expectations For 2026 And Beyond - Seeking Alpha
- 13 days ago - Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results - GlobeNewsWire
- 5 weeks ago - Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference - GlobeNewsWire
- 3 months ago - Premium Brands Holdings Corporation (PBH:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results - GlobeNewsWire